Results 131 to 140 of about 13,336 (197)

Genomic instability, postoperative recurrence and therapeutic vulnerabilities in resectable non‑small cell lung cancer (Review). [PDF]

Oncol Rep
Wang L, Feng Y, Liu Q.
europepmc   +1 more source

Dynamic regulation of origin firing factors links CDK activity to dormant origin activation. [PDF]

Nat Commun
Hossain MS, Sansam CG, Wittig KA, Noble TD, Boyd KA, Sansam CL.   +5 more
europepmc   +1 more source

Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer. [PDF]

Front Oncol
Karam MN, Hajj J, Crane CH, Ramia P, Geara F, Hamadeh N, Scott JG, Grobmyer S, Almond R, O'Reilly EM, Hajj C.   +10 more
europepmc   +1 more source

Structural Studies of βTrCP Reveal Plasticity in Binding Modes of Consensus and Nonconsensus Degrons. [PDF]

ACS Chem Biol
Collie GW, Mak H, Acebrón-García-de-Eulate M, Argyrou A, Couturier M, Cuomo ME, O Donovan DH, Russell IC, Wells G, Winter-Holt J.   +9 more
europepmc   +1 more source

Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach. [PDF]

Neoplasia
Pham AT, Yuan F, Nagathihalli NS, Dosch AR.   +3 more
europepmc   +1 more source

Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models. [PDF]

Sci Rep
Tamburello M, Boldini C, Abate A, Salvi V, Valcamonico F, Laganà M, Cosentini D, Suardi NR, Mirabella G, Altieri B, Sigala S.   +10 more
europepmc   +1 more source

Advances in molecular glue degraders for targeted protein degradation: Focus on NEK7, WEE1, CDK2, GSPT1 and VAV1. [PDF]

Asian J Pharm Sci
Cheng B, Wang Y, Hong Y, Zhou Y, Peng X, Chen J, Zeng C.   +6 more
europepmc   +1 more source

Patient-specific modeling of G2/M cell cycle dynamics reveals prognostic dynamical regimes driven by copy number alterations. [PDF]

NPJ Syst Biol Appl
Tonina A, Romanel A.
europepmc   +1 more source

Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor-Resistant Head and Neck Squamous Cell Carcinoma. [PDF]

Cancer Res Commun
Silva FN, Lee JW, Nguyen TT, Goeckel FM, Bagnyukova T, Borghaei H, Golemis EA, Burtness BA.   +7 more
europepmc   +1 more source

Current Research in Polypharmacology for Cancer Treatment Using Dual-Target Histone Deacetylase Inhibitors. [PDF]

Int J Mol Sci
Yudaev P, Aleksandrova Y, Neganova M.
europepmc   +1 more source